Clinical trial
Feasibility Assessment of Novel ECG-Based Continuous Glucose Monitoring System
NCT06883682 is registered in ClinicalTrials.gov with Singular Wings Medical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Assessment of Novel ECG-Based Continuous Glucose Monitoring System
- Lead sponsor
- Singular Wings Medical Co., Ltd.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 10, 2025
- Completion date
- September 30, 2025
- Enrollment
- 165 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.